These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 9335521)

  • 1. Clinical studies of docetaxel (Taxotere) and concomitant chest therapy.
    Vokes EE; Masters GA; Mauer AM; Haraf DJ; Hoffman PC; Golomb HM
    Semin Oncol; 1997 Aug; 24(4 Suppl 14):S14-26-S14-29. PubMed ID: 9335521
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of docetaxel (Taxotere) as a single agent or in combination before local treatment of non-small cell lung cancer.
    Harper P
    Semin Oncol; 1997 Aug; 24(4 Suppl 14):S14-30-S14-32. PubMed ID: 9335522
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The development of docetaxel (Taxotere) in non-small cell lung cancer--docetaxel in new combinations and new schedules: an overview of ongoing and future developments.
    Donnellan PP; Crown JP
    Semin Oncol; 1997 Aug; 24(4 Suppl 14):S14-18-S14-21. PubMed ID: 9335519
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Docetaxel (Taxotere) in combination with radiation therapy and the potential of weekly administration in elderly and/or poor performance status patients with advanced non-small cell lung cancer.
    Hainsworth JD; Vokes EE
    Semin Oncol; 2001 Feb; 28(1 Suppl 2):22-7. PubMed ID: 11284621
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Docetaxel in the treatment of non-small cell lung cancer: review of single-agent trials.
    Fossella FV
    Semin Oncol; 1999 Oct; 26(5 Suppl 16):17-23; discussion 41-2. PubMed ID: 10585004
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Docetaxel (Taxotere) as a single agent and in combination chemotherapy for the treatment of patients with advanced non-small cell lung cancer.
    Miller VA; Kris MG
    Semin Oncol; 2000 Apr; 27(2 Suppl 3):3-10. PubMed ID: 10810932
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Concurrent conventionally factionated radiotherapy and weekly docetaxel in the treatment of stage IIIb non-small-cell lung carcinoma.
    Koukourakis MI; Bahlitzanakis N; Froudarakis M; Giatromanolaki A; Georgoulias V; Koumiotaki S; Christodoulou M; Kyrias G; Skarlatos J; Kostantelos J; Beroukas K
    Br J Cancer; 1999 Aug; 80(11):1792-6. PubMed ID: 10468298
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combined modality therapy in non-small cell lung and esophageal cancer: a phase I dose-escalation study of docetaxel with concurrent radiotherapy.
    Vokes EE; Mauer AM; Hoffman PC; Haraf DJ
    Semin Oncol; 1998 Jun; 25(3 Suppl 8):28-32. PubMed ID: 9704674
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Docetaxel (Taxotere) and neoadjuvant chemotherapy for non-small cell lung cancer.
    Mattson K
    Semin Oncol; 1999 Jun; 26(3 Suppl 10):25-8. PubMed ID: 10437748
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Docetaxel (Taxotere) and vinorelbine in the treatment of non-small cell lung cancer.
    Georgoulias V; Kourousis C; Androulakis N; Kakolyris S; Papadakis E; Bouros D; Apostolopoulou F; Georgopoulou T; Agelidou M; Souglakos J; Halkiadakis G; Hatzidaki D
    Semin Oncol; 1997 Aug; 24(4 Suppl 14):S14-9-S14-14. PubMed ID: 9335517
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phase I study of docetaxel with concomitant thoracic radiation therapy.
    Mauer AM; Masters GA; Haraf DJ; Hoffman PC; Watson SM; Golomb HM; Vokes EE
    J Clin Oncol; 1998 Jan; 16(1):159-64. PubMed ID: 9440738
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Docetaxel (Taxotere) and vinorelbine in the treatment of advanced non-small cell lung cancer: preliminary results of a phase I/II trial.
    Miller VA
    Semin Oncol; 1997 Aug; 24(4 Suppl 14):S14-15-S14-17. PubMed ID: 9335518
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Docetaxel and radiation as combined-modality therapy.
    Kim ES; Khuri FR
    Oncology (Williston Park); 2002 Jun; 16(6 Suppl 6):97-105. PubMed ID: 12108904
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Emerging role of docetaxel (Taxotere) in advanced non-small cell lung cancer.
    Gandara DR; Edelman MJ; Lau D
    Semin Oncol; 1999 Jun; 26(3 Suppl 10):3-7. PubMed ID: 10437743
    [TBL] [Abstract][Full Text] [Related]  

  • 15. New approaches in the adjuvant and neoadjuvant therapy of non-small cell lung cancer, including docetaxel (Taxotere) combinations.
    Rosell R
    Semin Oncol; 1999 Jun; 26(3 Suppl 11):32-7. PubMed ID: 10458209
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combination treatment with docetaxel (Taxotere) and platinum compounds for non-small cell lung cancer.
    Mattson K; Saarinen A; Jekunen A
    Semin Oncol; 1997 Aug; 24(4 Suppl 14):S14-5-S14-8. PubMed ID: 9335516
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Summary of phase II data of docetaxel (Taxotere), an active agent in the first- and second-line treatment of advanced non-small cell lung cancer.
    Fossella FV; Lee JS; Berille J; Hong WK
    Semin Oncol; 1995 Apr; 22(2 Suppl 4):22-9. PubMed ID: 7740327
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Docetaxel (Taxotere) in combination: a step forward.
    Burris HA; Fields S; Peacock N
    Semin Oncol; 1995 Dec; 22(6 Suppl 13):35-40. PubMed ID: 8604452
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Weekly administration of docetaxel (Taxotere): summary of clinical data.
    Hainsworth JD; Burris HA; Greco FA
    Semin Oncol; 1999 Jun; 26(3 Suppl 10):19-24. PubMed ID: 10437747
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Docetaxel (Taxotere) administered in weekly schedules.
    Greco FA
    Semin Oncol; 1999 Jun; 26(3 Suppl 11):28-31. PubMed ID: 10458208
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.